2016 show at a glance

The 2016 show saw a record attendance of over 4,500 delegates, 100 exhibiting companies, and over 50 presentations by CEOs, founders and investment experts. It was the best show in Master Investor history and the biggest show of its kind in the UK.

Master Investor 2016 was a huge success, not only for the delegates, but also for our exhibitors looking for investors. One start-up took home more than 50 leads to investors who are eager to commit funds!

It is now the UK’s largest event for private investors.

Please visit our videos section to watch and download the Master Investor 2016 presentations.

Join the conversation

Twitter: @masterinvestor
Facebook: /masterinvestor
YouTube: Subscribe to the MasterInvestorChannel
Click HERE to read all news updates from the Master Investor Show



Alan Steel Asset Management | 10:00 – 10:30

Talk Title: Economic Tricks The Ibiza Mix

Alan Steel graduated from Edinburgh University in the summer of 1969, having studied Geography and Maths. Having convinced Scottish Widows that he was their missing link, he became a Trainee Actuary, but gave up when they discovered he could actually communicate with others and had a sense of humour – a cardinal sin in the actuary business.

After a spell as Training Manager at Scottish Provident, Alan became an IFA in January 1973, just nine months before the October 1973 stockmarket crash. He founded Alan Steel Asset Management in June 1975, and since then has survived far too many “Ends of the World”, recessions, crashes, rampant Inflation, volatile interest rates, mis-selling scandals, and many hundreds of ill designed tax and pension changes.

From the late 1980s he has written guest articles for a variety of newspapers, including a monthly column for the Scotsman for the best part of 25 years. He has been quoted in the Sunday Times, CA Magazine, and the Sunday Telegraph, and has appeared on BBC Moneybox, having what he calls “the perfect face for Radio”.

A fierce critic of political and regulatory interference and insurance industry trickery, Alan was the first person to put pen to paper, in April 1997, to accuse Equitable Life of rampant mis-selling. He then had to fight off their threat of legal action, but was vindicated three years later when their business collapsed – unfortunately taking with it the retirement hopes of many thousands of policyholders who were let down by the firm and the regulators.

Alan is passionate about his clients. Even at the age of 69, he still spends every weekday continually researching better ways to help investors gain a better understanding of how to plan to make their retirement enjoyable and tax effective.He claims to have been an Ibiza freak much longer than Jim lonlon, whom he first met in 1982 when they were “both poor”. Alan lives and breathes his industry, so it is perhaps not surprising that his hobbies are few. “Red wine and music plus the odd holiday are quite enough.”

Alan Steel Asset Management company profile


ICAP Securities and Derivatives Exchange | 11:10 – 11:40

Talk Title: Alternative market venues for public companies

Patrick Birley is CEO of inter-dealer broker ICAP Securities and Derivatives Exchange (ISDX). He is a long-time industry veteran with a substantial amount of executive experience, who ran LCH.Clearnet before becoming CEO of the European Climate Exchange back in 2007. Mr. Birley’s career started at the South African Futures Exchange (SAFEX), where he was the second employee. After spending 13 years as CEO, building it into one of the most active derivatives exchanges in the world, he led the sale of SAFEX to the Johannesburg Stock Exchange. He later became CEO and Risk Management director at LCH.Clearnet where he spent just over a year before joining the European Climate Exchange.

ICAP Securities and Derivatives Exchange company profile


Talk Title: The End of Deflation? | 12:10 – 12:40

Headline speaker Jim Mellon is famous for notching up the biggest ever success on the AIM market with Uramin, the company he co-founded in 2005 with $100,000 and sold in 2007 for $2.5 billion. With a substantial international property portfolio and interests in a variety of companies, particularly in the alternative energy and biotech sectors, Jim is a highly experienced and successful investor whose expert views were closely followed at last year’s Master Investor Show and will undoubtedly draw a large crowd again this year. With 96% of 2014 attendees rating his talk Good or Excellent, he’s sure to draw big crowds again.


Lenigas Cuba | 14:00 – 14:30

David Lenigas is a global entrepreneur and chairman of Lenigas Cuba. He has served as Executive Chairman of numerous public listed companies on London’s AIM and LSE markets, and is well-known for identifying and managing early-stage investment opportunities such as his time at UKOG – the company that discovered oil near Gatwick Airport. He has extensive experience operating in the public company environment across the UK, African, Canadian and Australian markets investing in multiple investment sectors.

Lenigas Cuba website


FastForward Innovations | 15:10 – 15:40

Talk Title: Fast Forward: the future, Now

Lorne Abony is a technology and media entrepreneur and the CEO of FastForward Innovations, Ltd, an investment company listed on the London Stock Exchange focusing on early stage technology investments. He is also the founder of EdTech companies Vemo Education and Schoold and serves on both companies’ boards as Non Executive Chairman. Abony currently owns the Orange County Breakers, a professional sports franchise which competes in World TeamTennis.

Abony is the former CEO of Mood Media Corporation, a public company listed on the Toronto Stock Exchange and the London Stock Exchange. He co-founded FUN Technologies in 2001 and in 2004 as CEO of FUN became the youngest CEO of a listed company on the Toronto Stock Exchange (TSX). Additionally, Abony, whose net worth is estimated at $300 million, is an accomplished tennis player and is a former member of the Competition Committee of the Association of Tennis Professionals (ATP).

FastForward Innovations company profile

Paul Lewis


Talk Title: Safe and simple in a dangerous and complex world | 16:20 – 16:50

Paul Lewis is a renowned financial journalist and commentator. Radio 4 listeners will know Paul as a presenter of Money Box and Money Box Live. He has written for Saga Magazine, Radio Times, Money Marketing and the Financial Times Money supplement.


Solo Oil Plc | 09:20 – 09:30

Mr Jenkins is a Chartered Engineer with a Bachelor of Engineering degree in Mining Engineering and a Master of Engineering degree in Petroleum Engineering. He has 20 years of experience working in industry, initially in mining before moving to petroleum. Mr Jenkins worked in a variety of technical and increasingly senior managerial positions in mid-sized independent oil companies, including Enterprise Oil, LASMO, OMV (UK) Ltd and Afren plc and he currently serves as Chief Operating Officer to the AIM-traded Leni Gas & Oil Plc.

Solo Oil Plc company profile


Oxford Technology | 09:30 – 09:40

Talk Title: Investing through the Oxford Technology (S)EIS Fund – the logical thing to do

Lucius Cary is the founder and managing director of Oxford Technology, which has specialised in making and managing investments in start-up technology-based businesses since 1983.

Prior to joining Oxford Technology, Andrea Mica worked in the entrepreneurial, technology and investment field – technology licensing, growing technology companies and identifying new technologies to invest in.

Oxford Technology has specialised in investing in technology start-ups since 1983. Almost all the investments are within an hour’s drive and Oxford Technology gets actively involved with its investees to help. The founders may be Nobel Laureates, but they will not before have established a price for a new product in a new market, or filled in a VAT return.

The talk will explain how Oxford Technology goes about its business using some of the investments in the most recent fund (including some of the bad investments!) as examples. How investments are sourced. How they are analysed. The process of making the investment. The involvement post-investment. Questions (if time allows).

Oxford Technology company profile


Critical Elements Corp | 09:40 – 09:50

Critical Elements is developing the Rose lithium-tantalum Deposit in Quebec. An independent economic assessment of the project prepared in 2011 by Genivar (WSP) showed a pre-tax NPV 8 of $488 million and a 33% IRR with a lithium carbonate price of $6000/t and $118/lb for tantalum. The project was designed to be open-pit with a mine life of 17 years. The company is now at the feasibility stage and well positioned to capture the rising lithium demand for battery products. With a lithium carbonate purity of 99.98% the Rose project demonstrates strong economics with high quality materials.

Critical Elements Corp company profile


The Penny Share Letter | 09:50 – 10:00

The Penny Share Letter company profile


Avation Plc | 10:30 – 10:50

Mr Richard Wolanski, B.Com, ACA, is a Chartered Accountant and his qualifications include a Bachelor of Commerce from the University of Western Australia. Mr Wolanski has extensive professional experience in the international finance industry. He has provided corporate, strategic and financial advisory assistance to public companies in Australia, Singapore and the United Kingdom. Mr Wolanski has significant corporate experience during his career serving in a range of Executive Director Chief and Financial Officer Company roles. In his current role as Finance Director at Avation Plc he is primarily responsible for maintaining access to capital, debt and equity profile and cost of debt capital.

Avation Plc company profile


iirx Plc | 10:50 – 11:10

Has been the Chief Executive Officer of Valirx plc since it listed on AIM on October 3rd in 2006. Having a strong background in the biotechnology industry, technology commercialization, equity financing and business management. Dr. Vainikka was trained as a molecular biologist and also holds a PhD in molecular biology from the University of Helsinki in Finland.

Following on she engaged in post-doctoral research with a prestigious EMBO fellowship in oncology at the Imperial Cancer Research Fund (now CRUK) where she undertook research in the field of oncology, working in the area of signal transduction pathways. Later she went on to work with a number of biotechnology companies prior to founding Valirx in conjunction with others.

Dr. Satu Vainikka also has an MBA from Imperial College Business School in London.

Valirx Plc company profile


LWP Technologies Ltd | 11:45 – 12:05

Talk Title: Developing innovative Australian technology for the global Oil & Gas Services industry

  • Chairman of Australian Stock Exchange (ASX) Listed LWP Technologies Limited.
  • Entrepreneur and early stage investor in emerging technology companies.
  • Successfully founded / developed / mentored 4 start-up Companies to IPO on ASX.
  • 30+ years’ experience in business management.
  • 25+ years as public company Director.
  • Global relationships in capital markets & public company sector.
  • Member, Australian Institute of Company Directors.

LWP Technologies Ltd company profile

JAMES PARSONS, Chief Executive Officer

Sound Energy Plc | 13:00 – 13:30

James Parsons has 23 years’ experience in the fields of strategy, management, finance and corporate development in the energy industry. James Parsons was appointed Chief Executive Officer in October 2012. James started his career with the Royal Dutch Shell group in 1994 and spent 12 years with Shell working in Brazil, the Dominican Republic, Scandinavia, Holland and London. Leading up to 2006 (when he left Shell to join Inter Pipeline Fund), James held various positions in Shell’s exploration and production business, latterly as Vice President, Finance, of New Business. James joined Sound Energy as Chief Financial Officer in 2011 from the European division of Inter Pipeline Fund, a Toronto-listed resources business, where he held the position of Finance and Corporate Development Director of Inter Pipeline Europe. James is a qualified accountant and has a BA Honours in Business Economics.

Sound Energy Plc company profile


UK Oil & Gas Investments Plc | 13:30 – 14:00

Stephen Sanderson joined UK Oil & Gas Investments PLC in September 2014 and was appointed Executive Chairman and Chief Executive in July 2015.

A highly-experienced petroleum geologist with over 30 years operating experience, Stephen is a proven oil finder and was instrumental in making the recent Horse Hill oil discovery near Gatwick Airport. The recent flow tests produced a rate of over 1,500 barrels of oil per day, the highest rate seen in any UK onshore well.

Stephen was previously instrumental in the discovery of more than 10 commercial conventional fields and held a variety of senior management roles for ARCO (which was acquired by BP in 2000) and Wintershall AG (a subsidiary of German chemical giant BASF). He created and ran successful new exploration businesses in Africa, Europe, the United States and South America.

He is a graduate and Associate of the Royal School of Mines, Imperial College, London, a Fellow of the Geological Society of London and a member of the American Association of Petroleum Geologists. He served for four years in the British Army and TAVR as a platoon commander, serving in the UK and Berlin.

UK Oil & Gas Investments Plc company profile


VectorVest | 14:30 – 14:50

Talk Title: Creating wealth, aggressively and safely on the London Stock Market with VectorVest

David Paul has been trading in the financial markets since 1982 and as a self-supporting trader since 1988. He is a qualified Mechanical Engineer with a PhD in applied Mathematics. His first job after University was with mining firm Anglo and was Head of Research for an Anglo subsidiary named Boart International prior to becoming a full time trader. In 1990 he began to move from unleveraged share trading to short term leveraged trading of the Ft100 contract and in the last 10 years to trading in the Foreign Exchange markets. His plan is to make cash from short term trading and to invest that cash in companies that are growing earnings both aggressively and safely. It’s the same model that Soros used in the Quantum Fund. In 1992 after speaking at an investment club he was asked to train a group of traders and this lead to a second career as a trading coach and mentor. Over the last 20 plus years he has done seminars in trading of stocks, futures and Forex all over the world. These seminars have been conducted at both retail and institutional level. In 2008 along with Tom Hougaard he started WhichWayToday. The company gives real time calls in stock indices and Forex markets. He still trades there and lends a hand when the full time traders needs a break. While in London during 2010 trading at Whichwaytoday he discovered the power of the VectorVest stock market trading program. He started there as a customer but became so happy with the product that he is, at the time of writing, the MD of VectorVest UK and VectorVest SA. He continues to trade short term for cash and to bank that cash into more solid longer term UK shares for both growth and dividend income using the VectorVest methodology.

VectorVest company profile


Symphony Environmental Technologies Plc | 15:00 to 15:10

Ian was in private practice for seven years, qualifying as a certified accountant in 1992. In 1994, he joined Brentapac UK Plc until it was sold in 1994. He went on to co-found Symphony Plastics in 1995.

Michael is the Chief Executive of the Company. Michael’s career began with his long established family packaging business, Brentwood Sack and Bag Co Limited. He took over responsibility for sales and production in the mid -1970s and changed the emphasis of the company’s business from jute products to polythene packaging, introducing the then innovative high density and medium density polythene bags into the UK market in 1975. He was appointed Managing Director of Brentapac UK Plc, which formerly owned the Tuffy trademark, in 1985, with continuing responsibility for national and international sales. He co-founded Symphony Plastics in 1995.

Symphony Environmental Technologies Plc company profile


Seven Investment Management | 15:40 – 16:00

Talk Title: Brexit, Grexit, fire exit

Justin was involved in the development of Big Bang in 1986 with BZW. From this he, with others, went on to found Broker Services which eventually went to become Barclays Stockbrokers where he was Corporate Development Director.

He is an enthusiast for greater financial education and the reform of investment structures for both investors and companies needing easier access for funding. As a result he has helped in the establishment of educational body Proshare, and also the development of the AIM market. Currently, he is keen on developing reforms for government privatisations as well as the development of regional investment structures for businesses of all sizes. He is a regular commentator and columnist on the media and is often called upon to demystify complicated financial jargon and stories.

He and his business partner of many years founded Seven Investment Management (7IM) in 2001 to provide some “radical common sense” to change “a lazy, lethargic and self-satisfied” investment industry which they saw as being primarily run for the benefit of itself rather its clients.

In March 2015 Justin won The Spectator Money Award for Lifetime Achievement.

Seven Investment Management company profile


Brought to you in association with London South East (www.lse.co.uk).


SyndicateRoom | 10:15 – 10:25

Gonçalo is the CEO and co-founder of SyndicateRoom, the UK’s only investor-led equity crowdfunding platform. SyndicateRoom gives its members access to the same investment opportunities that experienced business angels are investing in and gives entrepreneurs access to crowd capital alongside the mentoring and contacts from business angels. As a serial entrepreneur with a strong background in both business angel investment and equity crowdfunding, Gonçalo is one of the best-networked people in the industry and regularly writes for Forbes about entrepreneurship and early-stage equity.

SyndicateRoom company profile


Metal Tiger Plc | 10:25 – 10:35

Paul Johnson has been an active investor for more than 20 years and was a co-founder of MiningMaven, an investor communications service focused on the natural resources sector. His previous roles have included Business Risk Consulting Group Manager for FM Global and Regional Director for Capita McLarens.

Paul is a Chartered Accountant (England & Wales, 1996), an Associate of the Chartered Institute of Loss Adjusters (2000) and of the Chartered Insurance Institute (2005) as well as a Member of the Business Continuity Institute (2007). He holds a BSc (Hons) in Management Science (1991) from UMIST School of Management, Manchester, UK.

Metal Tiger Plc company profile


InterQuest Group | 10:35 – 10:45

Chris oversees the InterQuest Group’s activities across our specialist brands and our Solutions business. Chris is, himself, an expert recruiter with a strong technology background. Following his time studying Industrial Design and Engineering at Loughborough University, Chris has gone on to earn invaluable experience recruiting in the global technology sector, with particular focus on Digital, Big Data, Analytics, Security, Strategy & Architecture and Change & Transformation markets. Chris has worked with some of the largest global technology brands to early start-ups, both recruiting and advising on client change programs. Chris has recruited directly at a senior level over the last 20 years running businesses across a broad range of services including: MSP, RPO, executive search, permanent, interim & contract while leading businesses operating in Europe, USA and China; Chris’s experience, knowledge and skill for growing recruitment businesses in highly specialist, niche global markets made him a perfect fit to lead InterQuest Group in our next era of evolution.

InterQuest Group company profile


Intensity Therapeutics, Inc. | 10:45 – 10:55

Lewis H. Bender is the founder and currently President and CEO of Intensity Therapeutics, an in vivo stage biotechnology company pioneering a new therapeutic approach to treat cancer. Prior to founding Intensity, Mr. Bender was the CEO of two public biotechnology companies; Emisphere (listed on NASDAQ) and Interleukin Genetics (listed on AMEX). Mr. Bender is a pharmaceutical executive with over 23 years of drug development and business experience. He attended MIT for his SB and SM degrees in chemical engineering and the University of Pennsylvania’s Wharton School for his MBA in the USA. Mr. Bender has lived in Switzerland and speaks fluent French, German and Swiss-German.

Intensity Therapeutics, Inc. company profile


Cyan Technology Ltd | 10:55 – 11:05

John Cronin is a highly successful Chairman and CEO across international markets, in the Technology, Media and Telecommunications sectors including Smart Metering, IT Software, Telecommunications, Utilities and Managed Services. John’s contribution to high-tech industries includes key roles at Antenova, GCI Com, Aria Networks, Picochip, Arqiva, i2, Cambridge Networks, Netsource, Mercury (C&W). He has created significant value for shareholders with four company exits of Picochip, Azure Solutions, i2 and Netsource Europe totalling $600m.

Cyan Technology Ltd company profile


Rhinomed Ltd | 11:05 – 11:15

Michael is an experienced leader and innovator who has specialised in the successful commercialisation of emerging technologies and brands for over 20 years. Michael has worked in and for a wide spectrum of companies from ASX300 through to start-up companies in Life Sciences, Cleantech, Financial Services, Energy and Utilities, Manufacturing, Marketing and Communication. Michael’s most recent work has focused on helping companies envision and create new growth and innovation, manage and grow technology platforms and achieve sustainable growth through business model innovation.

Previous experience:

  • 20+ years high growth company experience
  • Principal and Co-Founder Cogentum
  • Principal and Co-Founder Athenaeum Capital
  • Director Cetus Energy
  • Principal Strategyn
  • Senior Associate Mercer
  • Senior Creative Leo Burnett

Rhinomed Ltd company profile


Scalable Capital | 11:15 – 11:25

Adam is Co-Founder and Managing Director of digital investment manager Scalable Capital. Prior to this, he spent the last 7 years working in London in the financial services industry at Goldman Sachs. As Executive Director of Commodities Trading, he was responsible for the commodity structured products franchise including risk management and developing client solutions. Prior to this, he worked in Derivatives Trading where he was responsible for electronic trading for private clients in fixed income, currency and commodity products. Adam studied Business Mathematics and Statistics at the London School of Economics and Political Science.

Scalable Capital company profile


SalvaRx Group Plc | 11:40 – 11:50

Ian B. Walters, M.D., is the Chief Executive Officer of SalvaRx Group PLC and part-time Chief Medical Officer of Intensity Therapeutics, Inc. Ian specialises in the evaluation, prioritization, and the innovative development of new therapies for the treatment of severe diseases.

Ian spent seven years at Bristol-Myers Squibb, where he managed physicians overseeing the international development of more than eight oncology compounds including Opdivo (Nivolimab) and Yervoy (Ipilimumab) among several others. He was a core member of Bristol- Myers Squibb’s Strategic Transactions Group evaluating and executing licensing agreements, mergers and acquisitions, clinical collaborations, and the company’s immuno-oncology strategy.

Before entering the private sector, Ian was a lead investigator at the Rockefeller University and initiated advanced immunology research to understand the mechanism of action of several compounds. Ian received his MD from the Albert Einstein College of Medicine and an MBA from the Wharton School of The University of Pennsylvania.

SalvaRx Group Plc company profile


Midatech Pharma Plc | 11:50 – 12:10

Dr Phillips has a strong background in company leadership and business development, and is a physician by training. He founded Talisker Pharma in 2004, which was the first and cornerstone acquisition of EUSA Pharma in 2006. As President of Europe and Senior Vice President, Corporate Development of EUSA Pharma Inc., Dr Phillips led the strategy resulting in the acquisition of OPI and its ultimate acquisition by Jazz Pharmaceuticals in 2012. Dr Phillips is currently a Non-executive Director of Herantis Pharma plc (listed in Helsinki), Insense Ltd (a private spin-out from Unilever), and, until joining Midatech, was Chairman of Prosonix Limited, guiding its successful transformation into a respiratory focused business.

Dr Phillips initially held senior positions at Johnson & Johnson and Novartis Pharmaceuticals. At Novartis, he was in Clinical & Business Development and was a Board Director of the $1.3bn Arthritis, Bone, Gastrointestinal, Haematology and Infectious Diseases business unit and a member of the company’s Clinical Leadership Team.

Midatech Pharma Plc company profile


13.00 – 13.30

Tomás Carruthers, Social Stock Exchange

Tomás Carruthers is Chief Executive Officer of the Social Stock Exchange (SSX). After two successful decades building and growing retail financial services companies – including ESI, which became E*Trade UK and Interactive Investor International Plc – Tomás is now committed to delivering not only great returns for investors, but a positive social or environmental impact, too. Tomás is passionate about innovation in finance and is determined to bring impact investing into the mainstream.

William Burckart, Burckart Consulting

William Burckart is the Founder and CEO of Burckart Consulting, an impact investing analytics and strategy firm, and serve as the President of The Investment Integration Project (TIIP). He is a visiting scholar at the US Federal Reserve and serves on the Global Advisory Council of Cornerstone Capital Group. Bill is the author of Bringing Impact Investing Down to Earth: Insights for Making Sense, Managing Outcomes, and Meeting Client Demand (2015), Serving Client Demand for Impact Investing: A Hands-on Guide for Financial Advisors and Senior Management (2014), and a contributing author to the New Frontiers of Philanthropy (2014).

Justin Urquhart Stewart, Seven Investment Management

Justin was involved in the development of Big Bang in 1986 with BZW. From this he, with others, went on to found Broker Services which eventually went to become Barclays Stockbrokers where he was Corporate Development Director.

He is an enthusiast for greater financial education and the reform of investment structures for both investors and companies needing easier access for funding. As a result he has helped in the establishment of educational body Proshare, and also the development of the AIM market. Currently, he is keen on developing reforms for government privatisations as well as the development of regional investment structures for businesses of all sizes. He is a regular commentator and columnist on the media and is often called upon to demystify complicated financial jargon and stories. He and his business partner of many years founded Seven Investment Management (7IM) in 2001 to provide some “radical common sense” to change “a lazy, lethargic and self-satisfied” investment industry which they saw as being primarily run for the benefit of itself rather its clients. In March 2015 Justin won The Spectator Money Award for Lifetime Achievement.

Peter Matthews, Capital for Colleagues Plc

Peter has nearly 30 years’ experience in helping to establish and manage consulting, advisory and investment management businesses, including over 16 years’ specialist experience in the Employee Owned Business sector. Most recently, from 2011 – March 2014, he was a Director of Baxi Partnership Ltd, a private employee owned business focused on supporting growth within the EOB sector, where his responsibilities included the development and management of the advisory and investment businesses. He is now a Director at Capital for Colleagues with responsibility for the Advisory Services.

Paul de Savary, Home from Home Care

12 years ago Paul, son Hugo and wife Ann, realised through the special needs of their daughter/sister, that the social care model was broken. Drawing on his 40 years of experience as an entrepreneur, Paul has led the family’s mission to improve specialist residential care and today, Home From Home Care is a leader in its niche market. Unique in the sector, every member of staff is connected into a single IT enabled care and management platform that is paperless, creates transparency, promotes collaborative working and evidences social impact. The system is now the focus of a number of significant third sector providers who see its potential to transform their sector – and beyond. Paul’s mantra is ‘Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it’s the only thing that ever has’


Condor Gold Plc | 13:30 – 13:40

Joined the Board of Condor Gold plc on the 24th May, 2006 as a non executive Chairman. Following the moratorium of all mining in El Salvador in 2008, Mr Child successfully repositioned the company in Nicaragua, acquiring 100% of ten concessions. Mr. Child is the largest shareholder with 8.5% of Condor Gold. He has provided the leadership from no resource to 2.5m oz gold resource, maiden reserves and permitting, spending 25% of his time in Nicaragua.

Mr. Child is a versatile, entrepreneurial senior executive with a speciality in emerging markets. He worked for 20 years in equity capital markets as an institutional stockbroker and in corporate finance/private equity. At board level Mr. Child has been an executive director of Hong Kong listed Regent Pacific Group, an emerging market fund manager and private equity group. He has been a Non Executive director of several private companies.

Condor Gold Plc company profile


Biohaven Pharmaceutical Holding Company Limited | 13:40 – 13:50

Talk Title: Novel Therapies Targeting Glutamate

Dr. Coric has a total of 15 years of drug discovery and clinical development at Yale University and Bristol-Myers Squibb. Within the pharmaceutical industry, Dr. Coric has expertise working in drug development across therapeutic areas including neuroscience, virology, oncology and immuno-oncology. He has been involved in multiple drug development programs including marketed drugs such as ABILIFY, DAKLINZA, SUNVEPRA, YERVOY and OPDIVO. Dr. Coric was the first to report the neuropsychiatric benefits of the glutamate modulating agent riluzole. He has conducted numerous clinical trials in various illnesses including obsessive compulsive disorder, generalized anxiety disorder, major depression, schizophrenia, schizoaffective disorder, Alzheimer’s disease, hepatocellular carcinoma, and glioblastoma. Dr. Coric is an Associate Clinical Professor of Psychiatry at the Yale School of Medicine and has over 50 peer-reviewed publications. Dr. Coric completed residency training at the Yale Psychiatry Residency Training Program and earned his medical degree at Wake Forest University School of Medicine.

Biohaven Pharmaceutical Holding Company Limited company profile


ANGLE Plc | 13:50 – 14:00

Andrew Newland is the founder and Chief Executive of ANGLE plc.

Andrew has an MA in Engineering Science from the University of Cambridge, and is a qualified Chartered Accountant. For over twenty five years, he has specialised in building technology-based businesses based on strong intellectual property and for the last fifteen years he has been Chairman or on the Board of several specialist medical technology companies.

ANGLE’s patented Parsortix micro-fluidic system captures circulating tumour cells (CTCs) in patient blood and harvests them for analysis for:

  • Early detection of cancer;
  • Personalised cancer treatment;
  • Monitoring of cancer patients during treatment; and
  • Post-treatment monitoring of cancer patients in remission.

ANGLE Plc company profile


SatoshiPay | 14:00 – 14:10

Meinhard founded SatoshiPay, a blockchain-based nanopayments provider aiming to fundamentally change the way web content is monetised. As open source developer, social entrepreneur and avid shoestring traveller with 50 countries under his belt, Meinhard experienced the need for an open, global and decentralised payment technology first-hand. He already experimented with different alternative payment systems for years when Bitcoin and its ground-breaking blockchain technology crossed his path in 2011. As developer, entrepreneur and speaker he pushes the blockchain ecosystem forward ever since.

SatoshiPay company profile


London South East Ltd | 14:30 – 14:30

Previously an Independent Financial Advisor (IFA), Scott brought relevant and insightful expertise to www.lse.co.uk upon joining the company as a Director in 2007.

Since then, www.lse.co.uk has grown its offering to Private Investors and become one of the foremost financial portals in the U.K.

With a belief in the simple and clean presentation of relevant financial information, Scott is committed to a ‘Customer first’ ethos in continuing to build www.lse.co.uk.

London South East company profile


Arrowhead Pharmaceuticals | 14:40 – 15:00

Dr. Christopher Anzalone has been President, Chief Executive Officer and a Director of Arrowhead Pharmaceuticals, Inc since December 2007. In 2005, Dr. Anzalone formed and served as CEO of the Benet Group, LLC, a private equity firm focused on creating and building new nano-biotechnology companies from university-generated science. Prior to his tenure at the Benet Group, he was a partner at the Washington, DC-based private equity firm Galway Partners, LLC, where he was responsible for sourcing, structuring, and building new business ventures. Prior to Benet, he was an NIH-supported post doctoral fellow in Reproductive Endocrinology at the Smithsonian Institution’s Conservation and Research Center. Dr. Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University.

Arrowhead Pharmaceuticals company profile


PulseFlow Technologies | 15:00 – 15:10

Les is CEO of PulseFlow Technologies and inventor of its core product PulseFlowDF.

PulseFlowDF utilises cutting edge, wearable technology to combine two gold-standard clinical therapies and state-of-the-art monitoring software to optimise wound healing in the diabetic foot.

Operating in a market worth $673 billion globally*, PulseFlowDF has regulatory clearance to sell in Europe and the USA. A new US office opened in Q1 2016 and the company is in the process of identifying distribution channels in new geographies.

(*IDF Diabetes Atlas 2015)

PulseFlow Technologies company profile


HarbourVest Global Private Equity Limited | 15:10 – 15:20

Talk Title: Investing in Private Companies

Richard Hickman is Director, Investment & Operations at HarbourVest Global Private Equity Limited (“HVPE”). The company’s primary investment objective is to offer shareholders long-term capital growth by investing in a private equity portfolio that is well diversified by phase, stage, geography, and strategy. HVPE is managed by an affiliate of HarbourVest Partners LLC, which has committed more than $35 billion to investments over its 33 year history.

HarbourVest Global Private Equity Limited company profile


Oxford Pharmascience Group Plc | 15:30 – 15:40

Marcelo Bravo is the founder of Oxford Pharmascience and an entrepreneur with a background in chemistry and chemical engineering and international experience with blue-chip companies. Marcelo spent 16 years in R&D with The Procter & Gamble Company and subsequently spent 3 years in corporate development with Boots (now Boots Alliance Plc). After this he became an entrepreneur and most recently was CEO and Board director of Oxford Advanced Surfaces Group Plc, a company he led from inception as a spin-out from Oxford University which is now quoted on the AIM market. Marcelo has extensive experience in developing, launching and growing new products and businesses across a range of both geographic and product markets. Marcelo holds a B.A. in Chemistry from the College of Wooster, USA and a B.Sc. in Chemical Engineering from Case Western Reserve University, USA and an M.Sc in Management from the London Business School.

Oxford Pharmascience Group Plc company profile


Red Rock Resources Plc & Regency Mines Plc | 15:40 – 16:00

Talk Title: Regency Mines Investment Case and Overview / Red Rock Resources Investment Case

Andrew Bell began his career as a natural resources analyst at Morgan Grenfell & Co. in the 1970s. His business experience encompasses periods in fund management and advisory work at leading financial institutions, international corporate finance work and private equity. Andrew Bell’s listed company directorships are Regency Mines plc (executive chairman), Red Rock Resources (executive chairman), Greatland Gold plc (non-executive chairman), and Jupiter Mines Limited (non-executive director).

Red Rock Resources company profile

Regency Mines company profile


All Street Research | 16:00 to 16:10

Emanuela Vartolomei is the founder and CEO of All Street Research, www.allstreet.org. She set up All Street Research with the purpose of reinventing finance for the information age. With a strong passion for supporting the emerging digital financial services ecosystem through financial education, Emanuela created All Street to help people investing in private markets. Before becoming a fintech entrepreneur, she worked in financial services across corporate banking and asset management, including roles at Citigroup, ABN AMRO, UniCredit and Dimensional Fund Advisors. Economist by training, she completed her MBA at Oxford University and holds degrees in Financial Management and European Development Studies.

All Street Research company profile


SHARES | 16:10 – 16:20

Talk Title: Is this the perfect stock?

Daniel Coatsworth is the Editor of SHARES and one of the country’s leading stock commentators. He has written about the stock market and investing since 2005. At the Master Investor show, Daniel will discuss an AIM-quoted company that has increased by more than 10 times in value since 2010, looking at the business in detail and giving the bull and bear cases.

SHARES company profile


The Master Investor Master Class | 09:30 – 12:00

Long time private investor and Adrian Kempton-Cumber, who you may know from his Master Investor blog posts, Final Word and TA columns in the magazine, hosts a morning course.

As private investors we have to avoid following the pack. Adrian will focus on creative ‘out of the box’ thinking and techniques to give you a competitive edge against other market participants. More ‘how to’ than ‘what to’, the intention is not to be prescriptive but to empower.

To hear more from Adrian Kempton-Cumber please follow the below link:



SyndicateRoom Investor Academy | 13:05 – 13:35

Gonçalo is the CEO and co-founder of SyndicateRoom, the UK’s only investor-led equity crowdfunding platform. SyndicateRoom gives its members access to the same investment opportunities that experienced business angels are investing in and gives entrepreneurs access to crowd capital alongside the mentoring and contacts from business angels. As a serial entrepreneur with a strong background in both business angel investment and equity crowdfunding, Gonçalo is one of the best-networked people in the industry and regularly writes for Forbes about entrepreneurship and early-stage equity.

SyndicateRoom company profile


Talk Title: USA Real Estate – one of the greatest opportunities in a generation! | 13:40 – 14:30

Andrew Cordle became a self-taught real estate investor, by attending meetings at local real estate investor clubs from a young age, gaining an understanding for the specific strategies for success, he completed his first real estate transaction when he was just 22 years of age.

By 2007 at the age of 25, Andrew was well on his way to wealth and financial security, he owned a very successful Real Estate business in Atlanta where he was wholesaling properties and growing at a very rapid rate. The Global Financial Crises (GFC) on the heels of the Sub-Prime debacle was a very painful learning period for the young entrepreneur. Andrew saw all his hard work and dedication start to disappear right before his eyes, he was faced with a choice, understandably he chose to fight, to learn and re-tool. He continued to learn from Real Estate clubs and associations, by using the basics that he had learned from the beginning he turned his business back around, and in the process learnt and further developed strategies for all phases of the market.

Three short years later and Andrew’s real estate business had recovered and was prospering, through the aptitude he had developed for real estate combined with his hard work and dedication, all inspirational attributes he learned at the real estate meetings and clubs. These local clubs had a truly profound impact on Andrew’s life, after all, he started out with very little, had gained knowledge and wealth through his involvement with them.

Andrew’s journey had not always been easy, but the one constant was his involvement with a group of mentors who had provided a sense of confidence and understanding, this ultimately had been a force in Andrew’s success. He knew he wanted to pass on this inspirational process, in a way start to pay it forward and assist others in the same way he had been, this led to Andrew starting the National Association of Real Estate Investors (NAREI).

Since then, Andrew has written an Amazon best-selling book that has clinched a top spot on the online marketplace for many consecutive weeks. He’s been interviewed by some of the most prestigious financial publications, such as Forbes magazine. He was also offered an opportunity to host his own radio show where he has the privilege of interviewing and ultimately continuing to learn from some of the most successful real estate investors in the country.

Andrew currently continues to give back by growing and expanding NAREI into a global organization providing the same grass roots wisdom he enjoyed to students all over the world. NAREI holds onto its humble beginnings by maintain its local investor meetings to create an educational channel for growth and developing exciting networking opportunities for its students. He continues to develop his business, when not teaching Andrew still wholesales, renovates, and rents properties, the passion that got him into Real Estate still burns brightly, he completed over 145 transactions in just an 18-month period.


Charles Schwab, London | 15:35 – 16:05

Talk Title: Helping you to get the most out of investing in the world’s largest stock market

Charles Schwab, U.K., Limited, based in London, has a team of U.S. licensed professionals here to help U.K. investors leverage the advanced online trading platforms, tools, and resources to access the U.S. market and achieve their financial goals.

Kully Samra is the Managing Director of Charles Schwab, U.K., Limited. He is based in the firm’s London office and is responsible for running all UK operations for Charles Schwab, U.K.. Ltd. Kully and his team assist UK based clients looking to invest in US markets.

Kully has over 17 years’ experience in US equities having worked in US equity institutional sales for Wachovia Securities and Thomas Weisel Partners. Kully has a bachelor’s degree in economics from Nottingham Trent University. Kully is a member of the Chartered Institute for Securities & Investment. He is also FINRA registered, holding Series 7,9, and 10 licenses.


Coast to Coast Education | 16:05 – 16:40

Talk Title: Caroline Drewett on setting up a business without any start-up capital

Caroline Drewett (29) is a self-made entrepreneur who started with no external funding while she was in her early twenties. Her education business now has offices on three continents and she manages her own property portfolio in London.

She will discuss the journey of being an entrepreneur and the realities of running a business whilst being in her twenties. How did she get started? What were the biggest hurdles to success? What advise does she have for anyone who is young and eager to get started as entrepreneur?

Her insights are very personal. She’ll cover the realities of not being in the tech industry behind a screen but rather on the ground, travelling from country to country and working on a global scale. Caroline will trace her journey from starting with nothing in 2009 to now having a business that literally operates around the world / clock.

She also writes a regular column on personal finances and investing for Millennials, which are published in the Master Investor magazine.


"A very good show indeed. Thank you to all those who worked hard to make it such a successful day. I rate this as a not to be missed event for anyone investing in the small cap sector." Matthew Clist (Investor)
"Having attended the event on several occasions in recent years, with Saxo Bank and previous companies, I consider the professionalism of the show to be highly complementary to Saxo Bank… the demographics of the delegates in attendance at Master Investor replicate the typical client of Saxo Bank." Stuart Rice, Director of Marketing and Sales, Saxo Bank
"Hi, I attended the show and was pleased that I did, I met several CEOs and Directors of small companies that I have invested in recently and that was interesting for me…well done all of you!" George Colman (Investor)


Master Investor 2016 Gallery